Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Nasopharyngeal Carcinoma 11 Squamous Cell Carcinoma of Head and Neck 6 Head and Neck Neoplasms 6 Thyroid Neoplasms 4 Neoplasm Metastasis 2 Nasopharyngeal Neoplasms 2 Thyroid Diseases 1 Sarcoma 1 Salivary Gland Neoplasms 1 Radioactive Iodine-refractory Differentiated Thyroid Cancer 1 Neoplasms, Connective and Soft Tissue 1 Neoplasms 1 Mouth Neoplasms 1 Locally Advanced Thyroid Gland Carcinoma 1 Epstein-Barr Virus Infections 1 Differentiated Thyroid Cancer 1

Interventions

selpercatinib 3 Sorafenib 3 cabozantinib 2 Thyroid (USP) 2 Sodium 2 Radiofrequency Ablation 2 Metformin 2 Data Collection 2 vandetanib 1 tomivosertib 1 temsirolimus 1 repotrectinib 1 pralsetinib 1 pembrolizumab 1 lenvatinib 1 binimetinib 1 apatinib 1 acetaminophen, codeine drug combination 1 Watchful Waiting 1 Vitamin B 12 1 Tramadol 1 Thyroxine 1 Thyrotropin-Releasing Hormone 1 Thyroidectomy 1 Technetium Tc 99m Sestamibi 1 Surgical Procedures, Operative 1 Pemetrexed 1 Panobinostat 1 Observation 1 Negative-Pressure Wound Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Thyroid Diseases × apatinib × Head & Neck × Clear all

NCT04180007 2019-11-27

APT-01

Nanjing First Hospital, Nanjing Medical University

Phase 2 Unknown

Neoplasm Metastasis, Thyroid Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡